{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-029250","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2023-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.225205+00:00","generated_at":"2026-06-11T07:41:08.586598+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Processa presents at Sidoti conference; no material financial data disclosed","bullets":["Company presented on August 17, 2023, at the Sidoti Micro-Cap Virtual Conference.","David Young, Pharm.D., Ph.D., presented the corporate update during Track 2 at 11:30 AM ET.","Presentation is available on Processa's website under the Investors section.","No specific clinical trial results, financial guidance, or pipeline changes were detailed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-029250","json":"https://secwatch.observer/filing/0001493152-23-029250.json","markdown":"https://secwatch.observer/filing/0001493152-23-029250.md","text":"https://secwatch.observer/filing/0001493152-23-029250.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315223029250/0001493152-23-029250-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315223029250/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T07:41:08.586598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}